Overactive Bladder and Urge Incontinence In Men: Current Oopinions, Medical and Surgical Management

00:00 1.
Overactive Bladder and Urge Incontinence in Men:Current Opinions, Medical, and Surgical Management
00:16 2.
LUTS (Lower Urinary Tract Symptoms): Voiding and Storage Symptoms
01:11 3.
Multifactorial Etiology
02:03 4.
Most men have BOTH voiding and storage symptoms
02:29 5.
Storage Symptoms
03:42 6.
Overactive Bladder Treatment
04:45 7.
Pharmacological Options
04:52 8.
Overactive Bladder Treatment
04:53 9.
Pharmacological Options
05:10 10.
Behavior Modification
06:06 11.
α1- Adrenergic Receptor Distribution & Function
06:23 12.
α1-Blockers and Overactive Bladder
07:23 13.
Antimuscarinic Mechanism
07:56 14.
Antimuscarinics
09:39 15.
Antimuscarinics
09:45 16.
Overactive Bladder:Antimuscarinics and their current challenges
10:14 17.
Combination: Alpha-blocker and Antimuscarinic agents
10:26 18.
Combination: Alpha-blocker and Antimuscarinic agents
11:00 19.
Beta-3 Agonist
11:38 20.
Beta-3 Agonist
11:58 21.
PDE5-Is
12:42 22.
Third-Line Options
13:08 23.
Surgical InterventionsOnabotulinumtoxinA in Refractory Overactive Bladder
13:51 24.
Intradetrusor Onabotulinum Toxin
14:11 25.
Conclusion
14:54 26.
Thank You for Your Attention

未登入或權限不足!

00:00 1.
Overactive Bladder and Urge Incontinence in Men:Current Opinions, Medical, and Surgical Management
00:16 2.
LUTS (Lower Urinary Tract Symptoms): Voiding and Storage Symptoms
01:11 3.
Multifactorial Etiology
02:03 4.
Most men have BOTH voiding and storage symptoms
02:29 5.
Storage Symptoms
03:42 6.
Overactive Bladder Treatment
04:45 7.
Pharmacological Options
04:52 8.
Overactive Bladder Treatment
04:53 9.
Pharmacological Options
05:10 10.
Behavior Modification
06:06 11.
α1- Adrenergic Receptor Distribution & Function
06:23 12.
α1-Blockers and Overactive Bladder
07:23 13.
Antimuscarinic Mechanism
07:56 14.
Antimuscarinics
09:39 15.
Antimuscarinics
09:45 16.
Overactive Bladder:Antimuscarinics and their current challenges
10:14 17.
Combination: Alpha-blocker and Antimuscarinic agents
10:26 18.
Combination: Alpha-blocker and Antimuscarinic agents
11:00 19.
Beta-3 Agonist
11:38 20.
Beta-3 Agonist
11:58 21.
PDE5-Is
12:42 22.
Third-Line Options
13:08 23.
Surgical InterventionsOnabotulinumtoxinA in Refractory Overactive Bladder
13:51 24.
Intradetrusor Onabotulinum Toxin
14:11 25.
Conclusion
14:54 26.
Thank You for Your Attention

長度: 15:48, 瀏覽: 773, 最近修訂: 2017-05-19

00:00 1.
Overactive Bladder and Urge Incontinence in Men:Current Opinions, Medical, and Surgical Management
00:16 2.
LUTS (Lower Urinary Tract Symptoms): Voiding and Storage Symptoms
01:11 3.
Multifactorial Etiology
02:03 4.
Most men have BOTH voiding and storage symptoms
02:29 5.
Storage Symptoms
03:42 6.
Overactive Bladder Treatment
04:45 7.
Pharmacological Options
04:52 8.
Overactive Bladder Treatment
04:53 9.
Pharmacological Options
05:10 10.
Behavior Modification
06:06 11.
α1- Adrenergic Receptor Distribution & Function
06:23 12.
α1-Blockers and Overactive Bladder
07:23 13.
Antimuscarinic Mechanism
07:56 14.
Antimuscarinics
09:39 15.
Antimuscarinics
09:45 16.
Overactive Bladder:Antimuscarinics and their current challenges
10:14 17.
Combination: Alpha-blocker and Antimuscarinic agents
10:26 18.
Combination: Alpha-blocker and Antimuscarinic agents
11:00 19.
Beta-3 Agonist
11:38 20.
Beta-3 Agonist
11:58 21.
PDE5-Is
12:42 22.
Third-Line Options
13:08 23.
Surgical InterventionsOnabotulinumtoxinA in Refractory Overactive Bladder
13:51 24.
Intradetrusor Onabotulinum Toxin
14:11 25.
Conclusion
14:54 26.
Thank You for Your Attention

位置

資料夾名稱

2015臺大攝護祭-醫藥護人員場

發表人

系統管理者

單位

泌尿部

建立

2017-05-19 17:16:56

最近修訂

2017-05-19 19:42:23

長度

15:48